NEXGEL, INC.
Public company- Headquarters
- LANGHORNE, Pennsylvania
- Ticker
- NXGL
- CIK
- 0001468929
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEOAdam R. Levy | Aug 21, 2026 | Departed |
| DirectorAdam R. Levy | Aug 21, 2026 | Departed |
| CEOBrian Kieser | Aug 21, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- TELEFLEX INC
director appointed: Sean M. Salmon
- TELA Bio, Inc.
principal financial officer appointed: Heather Getz
- Neuronetics, Inc.
interim principal financial and accounting officer appointed: Francis X. Brown III
- WEST PHARMACEUTICAL SERVICES INC
Plant closure: Frankfort, IN
- Executive departure
CEO departs: Adam R. Levy
Adam R. Levy, Chief Executive Officer of NEXGEL, INC., leaves the role, effective August 21, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 21, 2026Role: Chief Executive Officer
- Executive departure
Director departs: Adam R. Levy
Adam R. Levy, Director of NEXGEL, INC., resigns the role, effective August 21, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 21, 2026Role: Director
- Executive appointment
CEO appointed: Brian Kieser
Brian Kieser was named Interim Chief Executive Officer of NEXGEL, INC., effective August 21, 2026. Brian Kieser succeeds Adam R. Levy. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 21, 2026Role: Interim Chief Executive Officer
Last verified Nov 8, 2026